Brawn Biotech Limited (BOM:530207)
25.40
+1.15 (4.74%)
At close: Oct 16, 2026
Brawn Biotech Market Cap
Brawn Biotech has a market cap or net worth of 76.21 million as of October 16, 2026. It is the 49,788th most valuable company in the world and the 5,321st biggest in India. Its market cap has increased by 17.87% in one year.
Market Cap
76.21M
Enterprise Value
73.40M
Revenue
172.59M
Global Rank
Country Rank
#5,321 India
PE Ratio
8.77
ChartMarket Cap Chart
Since August 11, 2005, Brawn Biotech's market cap has increased from 23.22M to 76.21M, an increase of 228.17%. That is a compound annual growth rate of 5.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 76.21M | 18.08% |
| Dec 31, 2025 | 64.54M | 0.94% |
| Dec 31, 2024 | 63.94M | -2.69% |
| Dec 26, 2023 | 65.71M | 11.17% |
| Dec 30, 2022 | 59.11M | -13.79% |
| Dec 31, 2021 | 68.56M | -6.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Desh Rakshak Aushdhalaya | 153.28M |
| Shamrock Industrial Company | 147.84M |
| Unjha Formulations | 141.14M |
| Beryl Drugs | 120.76M |
| Ortin Global | 113.84M |
| Emmessar Biotech & Nutrition | 109.01M |
| Ganga Pharmaceuticals | 73.89M |
| Vivanza Biosciences | 68.00M |